Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)
Sponsor: Seoul National University Bundang Hospital
Summary
RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.
Official title: The ReInforcement of Adherence Via Self-monitoring App Orchestrating Biosignals and Medication of RivoXaban in Patients with Atrial Fibrillation and Co-morbidities: Randomised Control Study(RIVOX-AF Study)
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1042
Start Date
2022-03-10
Completion Date
2025-12-31
Last Updated
2025-01-28
Healthy Volunteers
No
Conditions
Interventions
MEDI-app
MEDI-app based feedback algorithm. The app based feedback algorithm will check and remind the patients of taking medication.
Locations (1)
Seoul National University Bundang Hospital
Seongnam, South Korea